Groowe Groowe / Newsroom / NTLA
⏱ News is delayed by 15 minutes. Sign in for real-time access. Sign in

NTLA News

Intellia Therapeutics, Inc

Dravet Syndrome Market Trends Indicate Sustained Growth During the Forecast Period (2026–2036), Driven by Novel Treatment Approaches | DelveInsight

globenewswire.com
BIIB HRMY XNCR AZN LLY PFE REGN NVS TSLA TAK GSK JNJ UCB BHF PRAX XENE AQST TNDM INCY MRK ABBV BMY AMGN GILD VRTX CRSP EDIT NTLA SRPT ALNY EXAS TEVA AXSM CYTK INSM KODK LPCN MNKD NBIX NCLH ONCY ORIC PBYI PEGA PLRX PRGS QGEN RGNX ROST RYAAY SNOW SWKS SYK TGT TRMB TXG ULTA VRSK WDC WVE XOM ZBRA ZNTL ZTS STOK IONS MOMO BBAR CTXR MBIO GNS NEON OVID BHVN

Biologics CDMO (2026-2031) - Growing Biologics Pipeline Drives Demand for Outsourced Development and Manufacturing

globenewswire.com
NVO TMO ABBV CAT EXEL REGN BMY PFE MRK AMGN GILD BIIB ISRG CRSP EDIT NTLA VRTX AZN SNY LLY JNJ XOM CVX

GenBio AI met au point le premier modèle mondial de la cellule humaine

businesswire.com
MRNA GILD BMY AZN PFE JNJ REGN AMGN BIIB VRTX CRSP NTLA EDIT NVDA GOOG MSFT

Global Fusion Biopsy Market to Register Sustainable Growth at a CAGR of ~6% by 2034 | DelveInsight

globenewswire.com
BSX CAH MDT GEHC XRAY AMGN AZN BMY LLY MRK PFE SNY TEVA JNJ BIIB GILD NVS GOOG MSFT IBM NVDA INTC AMD QCOM AMAT MU NXPI ASML ADI LRCX KLAC CDNS SNPS MCHP ON STM MRVL AEHR TER PAYX CTAS WST ZBRA VRSN NOW CRM ADBE PANW CSCO ACN HPQ ORCL SAP PTC ALGN ESTC DDOG SMCI EXAS CRSP EDIT BEAM NTLA REGN VRTX XOM CVX SHEL BABA JD PDD NTES BIDU IQ BILI VIPS HTHT EDU TAL MELI AMZN NFLX DIS CMCSA VZ T SIRI GOOGL AAPL META TSLA GE PHI BRKR AUR FONR BFLY CRI EXEL TAK ABSI JHG XNCR MOD ARVN CLAR BNTX FOR ORIC COOK OWL MTA SKIN HYPR ALLT MAGN

Global Neurodegenerative Disease Market is Expected to Showcase Significant Growth at a CAGR of ~6% by 2034 | DelveInsight

globenewswire.com
NVO LLY BMY AXSM JNJ SNY BIIB ABBV MRK REGN GILD AMGN AZN TEVA BHC ALKS VRTX SRPT CRIS NTLA EDIT INCY ACAD ALNY CYTK IONS EXAS IDXX VNDA SUPN RGNX XOM CVAC BNTX ARCT MRNA NBIX ADPT AVXL IMUX PRGS RDNT CRDF ADSK ANAB ATRC CLDX CPRX ESPR EXEL FGEN GALT GRFS HRMY IGC INSM KODK LAKE LCTX LEXX LPCN MESO MITK MNKD MSFT MYGN NEO NVCR NXPI OCGN OMER ORCL PACB PFE PLRX PRGO PSNL PTGX QGEN RARE ROST RVMD SEIC SIGA SMCI SNOW SOFI SPRO TGTX TNDM TXG ULTA VEEV VKTX VRNS WVE XRAY ZBRA ZNTL

Intellia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

globenewswire.com
NTLA

Form 8-K

sec.gov
NTLA

Intellia Therapeutics Announces Second Quarter 2026 Financial Results and Business Updates

globenewswire.com
NTLA

Intellia Therapeutics Announces Second Quarter 2026 Financial Results and Business Updates

globenewswire.com
NTLA

Intellia Therapeutics to Hold Conference Call on August 6 to Discuss Second Quarter 2026 Financial Results and Business Updates

globenewswire.com
NTLA